Literature DB >> 23478232

Premalignancy of the testis and paratestis.

Robert E Emerson1, Liang Cheng.   

Abstract

There has been great progress in the understanding of the molecular events involved in normal germ cell maturation and testicular tumour pathobiology. Identification of the molecules involved in these processes has provided a number of new immunohistochemical markers for intratubular germ cell neoplasia, unclassified (IGCNU) and germ cell tumours. OCT4, the most important of the newer markers, is highly sensitive and specific for IGCNU and is superior to older immunohistochemical markers for this purpose. However, germ cell maturation delay is a potential pitfall in the application of this marker. In contrast to the type II testicular germ cell tumours, relatively little is known about premalignant lesions of testicular sex cord-stromal tumours, malignancies of the rete testis and epididymis, and paratesticular malignancies.

Entities:  

Mesh:

Year:  2013        PMID: 23478232     DOI: 10.1097/PAT.0b013e32835f3e1a

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  3 in total

1.  Testicular germ cell tumors: the changing role of the pathologist.

Authors:  Andrea Ronchi; Francesca Pagliuca; Renato Franco
Journal:  Ann Transl Med       Date:  2019-09

Review 2.  Testicular biopsy in prepubertal boys: a worthwhile minor surgical procedure?

Authors:  Alice Faure; Aurore Bouty; Mike O'Brien; Jorgen Thorup; John Hutson; Yves Heloury
Journal:  Nat Rev Urol       Date:  2016-01-20       Impact factor: 14.432

Review 3.  Testicular cancer from diagnosis to epigenetic factors.

Authors:  Mariarosaria Boccellino; Daniela Vanacore; Silvia Zappavigna; Carla Cavaliere; Sabrina Rossetti; Carmine D'Aniello; Paolo Chieffi; Evzen Amler; Carlo Buonerba; Giuseppe Di Lorenzo; Rossella Di Franco; Alessandro Izzo; Raffaele Piscitelli; Gelsomina Iovane; Paolo Muto; Gerardo Botti; Sisto Perdonà; Michele Caraglia; Gaetano Facchini
Journal:  Oncotarget       Date:  2017-09-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.